Gds Wealth Management Astrazeneca PLC Transaction History
Gds Wealth Management
- $1.09 Billion
- Q4 2024
A detailed history of Gds Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Gds Wealth Management holds 4,973 shares of AZN stock, worth $343,435. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,973
Previous 5,709
12.89%
Holding current value
$343,435
Previous $444,000
26.8%
% of portfolio
0.03%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,340Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.34 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.9 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.57 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.54 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.32 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $214B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...